G. Walmsley Graham, Director at Akero Therapeutics, Inc. (AKRO), bought 520,000 shares at $42.00 ($15.4M) on 2023-05-19, disclosed to the SEC on 2023-06-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.00 | 400,000 | $10.4M | 67.4% |
| 2 | $42.00 | 120,000 | $5.0M | 32.6% |
| Total | $29.69 avg | 520,000 | $15.4M | 100% |
| Filing → |
| OLMA | SELL | 2024-12-18 | $9.5M | — | Filing → |
| OLMA | BUY | 2024-12-18 | $9.5M | — | Filing → |
| OLMA | BUY | 2024-12-17 | $4.7M | — | Filing → |